期刊文献+

PET/CT在非小细胞肺癌放射治疗中的应用现状 被引量:5

Application status of PET/CT in non-small cell lung cancer with radiotherapy
下载PDF
导出
摘要 随着多种放射治疗(以下简称"放疗")技术的发展,放疗已成为非小细胞肺癌(NSCLC)根治性及姑息性治疗的主要方法之一。放疗前准确分期和精确勾画靶区、治疗中评价肿瘤反应和修订治疗方案,放疗后评价疗效及早期检测复发对治疗NSCLC至关重要。PET/CT为功能与解剖融合技术,可提供肿瘤的代谢和形态信息。本文综述PET/CT在NSCLC临床分期、治疗方案选择、放疗靶区勾画、预后及复发评价中的应用现状。 With the development of a variety of radiotherapy techniques,radiotherapy has become one of the most important methods of radical and palliative treatment for non-small cell lung cancer(NSCLC).Accurate staging and target volume delineation before radiotherapy,evaluation of tumor response and revision of plan during radiotherapy and assessment of effect and early detection of recurrence after radiotherapy are critical components for a successful treatment of NSCLC with radiotherapy.PET/CT is a confluent technique of function and anatomy,which can provide anatomic information of CT and metabolic information of PET.This article reviewed the application status of PET/CT in clinical staging,choosing treatment project,delineating target volume,assessing prognosis and recurrence of NSCLC.
作者 梁萌 郑容
出处 《中国医学影像技术》 CSCD 北大核心 2014年第8期1276-1279,共4页 Chinese Journal of Medical Imaging Technology
基金 北京希望马拉松专项基金(LC2011A09)
关键词 非小细胞肺 放射疗法 体层摄影术 发射型计算机 Cancer non-small cell lung Radiotherapy Tomography emission-computed
  • 相关文献

参考文献21

  • 1Tyldesley S, Boyd C, Sehulze K, et al. Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologie approach. Int J Radiat Oneol Biol Phys, 2001,49(4) :973-985.
  • 2Bille A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracie lymph node staging in patients with non-small-cell lung cancer: Accuracy of integrated positron emission tomography and compu- ted tomography. Eur J Cardiothorac Surg, 2009,36(3) :440-445.
  • 3许泽清,段小蓓,贾晓娟,樊卫.^(18)F-FDGPET/CT诊断非小细胞肺癌纵隔淋巴结转移[J].中国医学影像技术,2013,29(12):1989-1993. 被引量:5
  • 4Opoka L, Kunikowska J, Podgajny Z, et al. Staging of non-small cell lung cancer using CT and integrated PET-CT. Pneumonol A1- ergol Pol, 2013,81(1):5-15.
  • 5Abramyuk A, Appold S, Zophel K, et al. Quantitative modifica- tions of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer sched-uled for radiotherapy--a retrospective study. Lung Cancer, 2012, 78(2) : 148-152.
  • 6Mutlu H, Buyukcelik A, Erden A, et al. Staging with PET-CT in patients with locally advanced non small cell lung cancer is su- perior to conventional staging methods in terms of survival. Asian PacJ CancerPrev, 2013,14(6) :3743-3746.
  • 7Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung canc- er. Int J Radiat Oneol Biol Phys, 2004,59(1) :78-86.
  • 8Van Baardwijk A, Bosmans G, Boersma L, et al. PET-CT-based autO-contouring in non-small-cell lung cancer correlates with pa- thology and reduces interohserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oneol Biol Phys, 2007,68(3) :771-778.
  • 9张华琦,于金明,孟雪,岳金波,冯瑞,马莉.18F-氟脱氧葡萄糖PET-CT显像预测Ⅲ期非小细胞肺癌的预后[J].中华肿瘤杂志,2010,32(8):603-606. 被引量:10
  • 10Huang W, Zhou T, Ma L, et al. Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging, 2011, 38(9) : 1628-1635.

二级参考文献17

共引文献13

同被引文献75

  • 1徐海峰,周润锁,袁梦晖,张金赫,王磊,周飞华.^(18)F-双脱氧葡萄糖全身PET显像寻找肿瘤原发灶的诊断价值[J].第四军医大学学报,2004,25(17):1618-1620. 被引量:8
  • 2陈宁波,麦刚.PET/CT在结直肠癌临床中的应用[J].华西医学,2008,23(6):1506-1507. 被引量:1
  • 3李松年.现代全身CT诊断学[M].北京:中国医药出版社,2007:1167-1168.
  • 4石远凯,牛奕.美国国家综合癌症网非小细胞肺癌治疗指南2007年第一版介绍[J].中华肿瘤杂志,2007,29(10):799-800. 被引量:35
  • 5Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61(2) :69-90.
  • 6Molina JR, Yang P, Cassivi SD, et al. Non-small cell lung canc- er: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proe, 2008,83 (5) : 584-594.
  • 7Skoura E, Datseris IE, Platis I, et al. Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non-small-cell lung cancer. Clin Lung Cancer, 2012,13(3) :181-187.
  • 8Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer prolif- eration correlates with IF-18] fluorodeoxyglucose uptake by posi- tron emission tomography. Clin Cancer Res, 2000, 6 (10) : 3837-3844.
  • 9Eisenhauer EA, Therasse P, Bogaerts J, et al. New response e- valuation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer, 2009,45(2) :228-247.
  • 10Wahl RL, Jacene H, Kasamon Y, et al. From RECIST to PER- CIST : Evolving Considerations for PET response criteria in solid tumors. J Nncl Med, 2009,50(Suppl 1) :122S-150S.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部